MPS advises of need for better awareness of cauda equina red flag symptoms

MPS advises of need for better awareness of cauda equina red flag symptoms

May 9 2018 The Medical Protection Society is advising doctors of a revision to the NICE Clinical...

Anticholinergics linked to increased risk of dementia

Anticholinergics linked to increased risk of dementia

April 30 2018 Anticholinergic drugs used in helping control some involuntary muscle movement...

Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

April 27 2018 Women and girls of childbearing potential must no longer take valproate medicines...

Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone...

Class of diabetes drug linked to increased risk of irritable bowel disease

Class of diabetes drug linked to increased risk of irritable bowel disease

March 29 2018 A study has shown that dipeptidylpeptidase-4 inhibitors may increase the risk of...

  • MPS advises of need for better awareness of cauda equina red flag symptoms

    MPS advises of need for better awareness of cauda equina red flag symptoms

    Wednesday, 09 May 2018 16:01
  • Anticholinergics linked to increased risk of dementia

    Anticholinergics linked to increased risk of dementia

    Monday, 30 April 2018 12:20
  • Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

    Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

    Friday, 27 April 2018 12:12
  • Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

    Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

    Monday, 23 April 2018 16:59
  • Class of diabetes drug linked to increased risk of irritable bowel disease

    Class of diabetes drug linked to increased risk of irritable bowel disease

    Thursday, 29 March 2018 11:49

a vaccination syringes image cbOctober 23 2017

A shortage of the pneumococcal polysaccharide vaccine has promoted a Chief Medical Officer letter to GPs recommending how stocks can best be managed.

The current shortage of the PPV23 vaccine is anticipated to continue for some time. “There is only one licensed vaccine available and although the company are expecting more stock deliveries during October, the volume anticipated is unlikely to be sufficient to vaccinate the whole 65 year old cohort this winter,” says the letter from the Welsh CMO and NHS Wales Medical Director Dr Frank Atherton.

He summarises the three main recommendations in the letter as:

  • practices should plan to deliver the bulk vaccine programme across the year;
  • for patients at high risk, it is important to ensure that other preventive measures, including influenza vaccination, are implemented;
  • the records of such patients should be flagged so that they can be called for vaccine once the stock situation improves.

A table sets out priority groups for PPV23 vaccination, ranking them into high, moderate and low priority. The letter notes that “there is no shortage of the PCV13 vaccine used in infants and toddlers but this vaccine is not suitable for protection of older people.”

Links:
GP One coverage              
CMO letter CEM/CMO/2017/4b

Clinical News

May 24 2018 Patients who see the same GP over time are admitted to hospital less often than similar individuals who see the same GP less often, a report has noted.
May 24 2018 Patients who see the same GP over time are admitted to hospital less often than similar individuals who see the same GP less often, a report has noted. The Health Foundation has examined...